C

Curis
D

CRIS

1.84000
USD
0.02
(0.82%)
مغلق
حجم التداول
400
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
22,081,306
أصول ذات صلة
A
ARRY
0.22500
(3.37%)
6.90000 USD
C
CLDX
0.110
(0.47%)
23.360 USD
C
COCP
-0.05000
(-3.03%)
1.60000 USD
E
EXEL
0.790
(1.76%)
45.600 USD
N
NERV
0.16000
(8.08%)
2.14000 USD
المزيد
الأخبار المقالات

العنوان: Curis

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.